SCHEMBL4553631

SCHEMBL4553631

CCCCC(=O)C(NCCNC(=O)C(Cc1ccccc1)C(=O)NO)c1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 4/20 0.41
MME P08473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL840619 0.81 AGTR1 (0.46) MMP8
SCHEMBL841345 0.81 AGTR1 (0.45) MMP8
SCHEMBL840227 0.78 MMP8 (0.41) MMP8MME
SCHEMBL4554039 0.78 AGTR1 (0.36)
SCHEMBL840869 0.77 AGTR1 (0.52) MMP8
SCHEMBL839955 0.76 MMP8 (0.43) MMP8MME
SCHEMBL841032 0.76 MMP8 (0.44) MMP8MME
SCHEMBL839449 0.75 AGTR1 (0.49) MMP8
SCHEMBL839448 0.75 AGTR1 (0.49) MMP8
SCHEMBL839972 0.74 AGTR1 (0.49) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132187-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2009-12-16 EP disclosed
WO-2008097459-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2008-08-14 WO disclosed